Company Name, Ticker, Customers, else..

Haemonetics Corporation (HAE)

Other Ticker:

Sector • Healthcare Industry • Medical Equipment & Supplies

Industry • Medical Equipment & Supplies

Sector • Healthcare

Haemonetics Corporation

HAE's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

HAE Growth rates comparisons

Looking into Haemonetics growth rates, revenue grew by 17.53 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 1662

Medical Equipment & Supplies industry recorded growth of revenues by 5.31 %

Haemonetics's net income grew by 41.8 % in III. Quarter 2022 year on year, above company average,

• More on HAE's Growth

HAE's Valuation comparisons

Haemonetics
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Haemonetics PEG ratio is at 0.13 Haemonetics realized cash outflow of $ -0.25per share in trailing twelve-month period.

Company

41.88

PE TTM

Industry

45.91

PE TTM

Company's Price to Sales ratio is at 3.51.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.

• More on HAE's Valuation

Total Debt (Millions $)	767
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	7.04
Tangible Book Value (Per Share $)	0.50

HAE's Valuation comparisons

Haemonetics
current PE on trailing twelve month basis is below Medical Equipment & Supplies industry average.

Haemonetics PEG ratio is at 0.13 Haemonetics realized cash outflow of $ -0.25per share in trailing twelve-month period.

Company

41.88

PE TTM

Industry

45.91

PE TTM

Company's Price to Sales ratio is at 3.51.
Medical Equipment & Supplies industry's Price to Sales ratio is at 3.56.

Haemonetics Price to Book Ratio is at 5.11 lower than Indusry Avg. of 485.92. and higher than S&P 500 Avg. of -0.01

• More on HAE's Valuation

• Market Capitalization (Millions $)	3,965
• Shares Outstanding (Millions)	51
• Employees	-
• Revenues (TTM) (Millions $)	1,129
• Net Income (TTM) (Millions $)	96
• Cash Flow (TTM) (Millions $)	-13
• Capital Exp. (TTM) (Millions $)	-133
• Total Debt (Millions $)	767
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	7.04
• Tangible Book Value (Per Share $)	0.50

• Market Capitalization (Millions $)	3,965
• Shares Outstanding (Millions)	51
• Employees	-
• Revenues (TTM) (Millions $)	1,129
• Net Income (TTM) (Millions $)	96
• Cash Flow (TTM) (Millions $)	-13
• Capital Exp. (TTM) (Millions $)	-133

HAE's Profitability Comparisons
Haemonetics faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 14.18 % from 15.71 % in II. Quarter. Haemonetics net profit margin of 10.79 % is currently ranking no. 27 in Medical Equipment & Supplies industry, ranking no. 105 in Healthcare sector and number 1173 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	3.11
• Total Debt to Equity (MRQ)	0.99
• Tangible Leverage Ratio (MRQ)	38.6
• Asset Turnover Ratio (TTM)	0.61
• Inventory Turnover Ratio (TTM)	1.89

HAE's Profitability Comparisons

Haemonetics faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2022 to 14.18 % from 15.71 % in II. Quarter.

Haemonetics net profit margin of 10.79 % is currently ranking no. 27 in Medical Equipment & Supplies industry, ranking no. 105 in Healthcare sector and number 1173 in S&P 500.

• More on HAE's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar TPST's Profile Stock Price TPST's Financials Business Description Fundamentals Charts & Quotes TPST's News Suppliers TPST's Competitors Customers & Markets Economic Indicators TPST's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071